Chimeric Therapeutics Limited (CHMMF)
OTCMKTS · Delayed Price · Currency is USD
0.0010
-0.0290 (-96.67%)
At close: Sep 6, 2024
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of $6.27 million as of February 12, 2026. Its market cap has increased by 7.95% in one year.
Market Cap
6.27M
Enterprise Value
2.18M
Revenue
8.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 74.92M to 6.27M, a decrease of -91.63%. That is a compound annual growth rate of -38.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 6.27M | 14.36% |
| Dec 31, 2025 | 5.48M | -19.66% |
| Dec 31, 2024 | 6.82M | -60.60% |
| Dec 29, 2023 | 17.32M | -27.14% |
| Dec 30, 2022 | 23.77M | -62.54% |
| Dec 31, 2021 | 63.45M | -15.32% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NKGen Biotech | 7.84M |
| Curative Biotechnology | 7.75M |
| BetterLife Pharma | 7.44M |
| Synlogic | 7.17M |
| LakeShore Biopharma | 6.63M |
| Brainstorm Cell Therapeutics | 6.29M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.30M |